Home › with Excess of Blasts Refractory Anemia › Washington
with Excess of Blasts Refractory Anemia clinical trials in Washington, DC
3 studies for with Excess of Blasts Refractory Anemia are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
RecruitingPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
with Excess of Blasts Refractory Anemia trials in other cities
- Houston, TX6 studies
- Seattle, WA5 studies
- New York City, NY3 studies
- Boston, MA3 studies
- Columbus, OH3 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.